Complications of pancreatitis

Severe forms and specific complications

A severe course of the disease often leads to necrotizing pancreatitis (pancreatic necrosis), which is a direct indication for surgical intervention. Pharmacotherapy with proteolytic enzyme inhibitors (aprotinin, octreotide) is used to suppress pancreatic autoagglutination/autoaggression.

Specific complications include:

• Formation of pseudocysts.
• Development of pancreatic fistulas.
• Development of severe exocrine insufficiency (e.g., following pancreatic necrosis or in the setting of chronic calcifying pancreatitis).

Nutritional support tactics play a key role: in the acute phase of a severe condition, the patient is prescribed parenteral nutrition exclusively. Transition to enteral nutrition (per os) should be carried out extremely gradually and with great caution.

Laboratory diagnostics of complications

To fully assess the degree of pancreatic damage and exocrine function, not only blood plasma but also other biological fluids are examined:

1. Fecal pancreatic elastase-1: recommended as the primary diagnostic method for exocrine insufficiency. A drop in the value below 200 mcg/g indicates severe functional deficiency and requires special attention to the dosage of enzyme replacement therapy.
2. Urine amylase (diastase): determined strictly in parallel with serum blood amylase. This marker is particularly valuable when it is necessary to diagnose pancreatitis developing as a complication of other diseases (e.g., in mumps infection).

Instrumental diagnostics and biopsy

In pancreatic trauma, MRI allows the detection of a hyperintense hematoma (on T1- and T2-weighted images). The use of gadolinium contrast enhancement helps identify major parenchymal defects caused by a pancreatic fracture. Rupture of the main pancreatic duct leads to the formation of disconnected duct syndrome (disconnected duct syndrome).

For the differential diagnosis of masses (pseudocysts, mucinous, and serous tumors), 18-gauge needle biopsy is used:

• Core needle biopsy (16–18 G needles) provides an adequate tissue core for histological examination.
• Fine-needle aspiration biopsy (FNAB) is used percutaneously under ultrasound guidance to collect fluid for cytology.

The procedure has high sensitivity, but in 15% of cases causes mild to moderate complications (abdominal pain). Rare but severe consequences include massive hemorrhage and needle-track seeding.

Fluid collection drainage

Pancreatic and peripancreatic fluid collections arising against the background of acute inflammation are amenable to percutaneous drainage.

Main indications for the procedure:

1. Assessment of fluid collection infection status.
2. Drainage of a known infected focus or abscess.

If a patient with acute pancreatitis exhibits fever, FNAB is performed under ultrasound or CT guidance to collect fluid. Immediate microbiological analysis is performed, and if infection is confirmed, a drainage catheter is placed during the same session.

A feature of pancreatic abscesses is viscous contents. Large-diameter catheters (12 F or larger) are required for adequate outflow. Best results are achieved with separate drainage of multiple abscesses using additional large catheters under strict fluoroscopic control. Important limitation: percutaneous drainage of liquefied walled-off pancreatic necrosis (walled-off necrosis) is generally not recommended.

Class and exam questions

What else to study on this topic

• Mechanisms of action of proteolytic enzyme inhibitors (aprotinin, octreotide) in pancreatic autoaggression.
• Pathogenesis and radiologic signs of disconnected duct syndrome.
• Differential diagnosis of serous and mucinous cystic tumors using FNAB.
• Causes of percutaneous drainage failure in walled-off pancreatic necrosis.
• Specifics of calculating enzyme replacement therapy dosage when elastase-1 levels are below 200 mcg/g.

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.